Literature DB >> 10518035

Effects of CB(1) cannabinoid receptor activation on cerebellar granule cell nitric oxide synthase activity.

C J Hillard1, S Muthian, C S Kearn.   

Abstract

Cerebellar granule cells (CGCs) express the CB(1) subtype of cannabinoid receptor. CB(1) receptor agonists Win 55212-2, CP55940 and HU210 inhibit KCl-induced activation of nitric oxide synthase (NOS) in CGCs. Win 55212-2 has no effect on either basal NOS activity or on activation by N-methyl-D-aspartate and its effect is abolished by pre-treatment of the cells with pertussis toxin. The CB(1) receptor antagonist/inverse agonist SR141716A both reverses the effects of Win 55212-2 and produces an increase in NOS activity that is additive with KCl. These results support the hypothesis that activation of the CB(1) receptor in CGCs results in a decreased influx of calcium in response to membrane depolarization, resulting in a decreased activation of neuronal NOS.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10518035     DOI: 10.1016/s0014-5793(99)01253-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  27 in total

1.  Cannabinoid CB(2) receptors modulate ERK-1/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharide.

Authors:  Stefania Merighi; Stefania Gessi; Katia Varani; Carolina Simioni; Debora Fazzi; Prisco Mirandola; Pier Andrea Borea
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 2.  Endocannabinoids in cerebrovascular regulation.

Authors:  Zoltán Benyó; Éva Ruisanchez; Miriam Leszl-Ishiguro; Péter Sándor; Pál Pacher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-01-29       Impact factor: 4.733

Review 3.  Cannabinoid receptors: nomenclature and pharmacological principles.

Authors:  Linda Console-Bram; Jahan Marcu; Mary E Abood
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-02-28       Impact factor: 5.067

4.  Transient receptor potential vanilloid subtype 1 mediates cell death of mesencephalic dopaminergic neurons in vivo and in vitro.

Authors:  Sang R Kim; Da Y Lee; Eun S Chung; Uh T Oh; Seung U Kim; Byung K Jin
Journal:  J Neurosci       Date:  2005-01-19       Impact factor: 6.167

5.  Long-term behavioral and biochemical effects of an ultra-low dose of Δ9-tetrahydrocannabinol (THC): neuroprotection and ERK signaling.

Authors:  Miriam Fishbein; Sahar Gov; Fadi Assaf; Mikhal Gafni; Ora Keren; Yosef Sarne
Journal:  Exp Brain Res       Date:  2012-07-22       Impact factor: 1.972

6.  Distinct regulation of nNOS and iNOS by CB2 receptor in remote delayed neurodegeneration.

Authors:  S Oddi; L Latini; M T Viscomi; E Bisicchia; M Molinari; M Maccarrone
Journal:  J Mol Med (Berl)       Date:  2011-12-24       Impact factor: 4.599

Review 7.  Hypothalamic or Extrahypothalamic Modulation and Targeted Temperature Management After Brain Injury.

Authors:  Rishabh Charan Choudhary; Xiaofeng Jia
Journal:  Ther Hypothermia Temp Manag       Date:  2017-05-03       Impact factor: 1.286

Review 8.  Role of cannabinoids and endocannabinoids in cerebral ischemia.

Authors:  Cecilia J Hillard
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

9.  Colocalization of cannabinoid receptor 1 with somatostatin and neuronal nitric oxide synthase in rat brain hypothalamus.

Authors:  Shenglong Zou; Rishi K Somvanshi; Seungil Paik; Ujendra Kumar
Journal:  J Mol Neurosci       Date:  2014-07-08       Impact factor: 3.444

10.  Cannabinoid regulation of nitric oxide synthase I (nNOS) in neuronal cells.

Authors:  Skyla T Carney; Michael L Lloyd; Shanta E MacKinnon; Doshandra C Newton; Jenelle D Jones; Allyn C Howlett; Derek C Norford
Journal:  J Neuroimmune Pharmacol       Date:  2009-04-14       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.